GHRP-2 (Pralmorelin)
Overview
GHRP-2 (Growth Hormone Releasing Peptide-2, also called Pralmorelin) is a synthetic hexapeptide ghrelin-receptor agonist and one of the most potent GH-releasing peptides. Its D-amino-acid content gives it stability and potency, and it has been used both in preclinical work and as a diagnostic probe of growth-hormone reserve. It is a research compound.
Chemical Profile
| Property | Value |
|---|---|
| CAS number | 158861-67-7 (free base) |
| Class | Hexapeptide GHSR-1a agonist |
| Amino-acid sequence | H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂ |
| Molecular formula | C₄₅H₅₅N₉O₆ |
| Molecular weight | ≈ 817.9 g/mol |
| Purity (HPLC) | ≥ 98% |
| Appearance | White to off-white lyophilized powder |
- Class
- Hexapeptide GHSR-1a agonist
- Other name
- Pralmorelin
- Research status
- Clinical research (GH diagnostic, catabolic states)
- Study routes
- Subcutaneous, intravenous
- Half-life
- ≈ 30 min
- Key feature
- One of the most potent GHRP agonists
Mechanism of Action
GHRP-2 is a potent GHSR-1a agonist. Its several D-amino acids resist proteolysis and give it high potency, and it produces a strong GH pulse. It raises prolactin somewhat more than the highly selective Ipamorelin, but less than the first-generation GHRP-6.
| Component | Detail |
|---|---|
| Primary target | GHSR-1a (ghrelin receptor) |
| Potency | Among the highest of the GHRPs |
| G-protein coupling | Gαq/11 → PLC → IP₃ → Ca²⁺ |
| GH release | Strong pulse amplification |
| Prolactin | Mild elevation (less than GHRP-6) |
| Cortisol | Minimal at low levels |
Pharmacology
| Parameter | Value |
|---|---|
| Half-life (t½) | ≈ 30 min (plasma) |
| Bioavailability (SC) | ≈ 70–80% |
| Time to peak (Tmax) | ≈ 15–20 min |
| Metabolism | Proteolytic degradation |
| Route of administration | Subcutaneous, intravenous |
| Elimination | Renal (peptide fragments) |
Research Evidence
Representative studies and their focus are named below; specific numerical outcomes are not restated here as claims.
| Study type | Research focus | Reference |
|---|---|---|
| Pituitary / animal models | Potent GH pulse amplification | Bowers CY, et al. |
| Human GH-stimulation testing | GH-reserve diagnostic use | GHRP-2 clinical literature |
| Catabolic-state research | GH/IGF-1 responses | GH-secretagogue literature |
Representative reported directions from the literature (qualitative; GLP-1 entries reflect published clinical-trial results, others are reported study directions, not restated as precise product claims):
| Reported direction / finding | Context | Reference |
|---|---|---|
| Strong GH pulse amplification (high potency) | pituitary / animal models | Bowers CY et al. |
| Used as a GH-reserve diagnostic probe | human GH-stimulation testing | GHRP-2 clinical literature |
For laboratory research use only. Not for human or veterinary use, diagnosis, or therapeutic application. Descriptions refer to published research contexts and are not medical or product claims.
Dosing & Reconstitution Reference
Reconstitution and handling parameters for laboratory research. Not dosing guidance for human use.
| Parameter | Reference value |
|---|---|
| Research dose range (literature) | ≈ 100–300 µg per injection, in study protocols |
| Reconstitution solvent | Bacteriostatic water (0.9% benzyl alcohol) |
| Storage (lyophilized) | −20°C, protected from light |
| Storage (reconstituted) | 2–8°C, up to ~2–4 weeks |
| Do not use | If the solution is cloudy or contains particulates |
Safety Profile
Published research observations, provided for reference only. This material is not for human or veterinary use.
| Category | Published observations |
|---|---|
| Local tolerability | Mild injection-site reactions |
| Prolactin / cortisol | Mild prolactin rise; minimal cortisol at low levels |
| Appetite | Moderate (ghrelin-receptor effect) |
| Status | For research use only; not for human or veterinary application |
Physicochemical Properties
| Property | Value |
|---|---|
| Physical state | White to off-white lyophilized powder |
| Solubility (water) | Freely soluble |
| logP | ≈ −1.2 (hydrophilic) |
| pH (reconstituted) | 5.0–6.5 |
| Stability (lyophilized) | ≥ 24 months at −20°C |
Synthesis & Manufacturing
GHRP-2 is a C-terminally amidated hexapeptide made by Fmoc solid-phase synthesis. The D-alanine, D-2-naphthylalanine and D-phenylalanine residues need their dedicated D-configured building blocks.
| Step | Detail |
|---|---|
| Strategy | Fmoc solid-phase peptide synthesis |
| Resin | Rink amide resin (C-terminal amide) |
| Special residues | D-Ala, D-2-Nal, D-Phe |
| Coupling | HBTU / HOBt with DIPEA |
| Cleavage | TFA / TIPS / H₂O (95 : 2.5 : 2.5) |
| Purification | Preparative RP-HPLC (C18, TFA/ACN gradient) |
- Notes: coupling efficiency and complete Fmoc removal are monitored each cycle; hindered or repeated residues (e.g. Arg-Arg) may need double coupling.
- Preparative RP-HPLC removes deletion and truncation impurities to reach research-grade purity; salt exchange (lyophilization from dilute HCl) removes residual TFA/acetate.
- Critical quality attributes: correct molecular weight and low deletion-peptide content. Tryptophan is light-sensitive; confirm the D-configured residues.
Analytical Methods
| Method | Parameter | Typical result |
|---|---|---|
| RP-HPLC (C18, UV 214 nm) | Purity | ≥ 98% |
| HPLC retention | C18, reversed-phase TFA/ACN gradient | Single main peak |
| ESI-MS (positive mode) | Identity / mass | [M+H]⁺ ≈ 818 Da |
| MALDI-TOF | Mass confirmation | [M+H]⁺ ≈ 818 Da |
| Amino-acid analysis | Composition | Consistent with the stated sequence |
| LC-MS (extracted ion) | Deletion-peptide impurities | Within specification |
| Karl Fischer | Water content | < 6% |
| LAL assay | Endotoxin | Within specification |
| Ion chromatography | Residual TFA | < 500 ppm |
Representative RP-HPLC purity method:
- Column: C18, 5 µm, 250 × 4.6 mm
- Mobile phase A: 0.1% TFA in water · Mobile phase B: 0.1% TFA in acetonitrile
- Gradient: reversed-phase TFA/ACN gradient · Flow rate: 1.0 mL/min · Detection: UV 214 nm
- Confirmatory LC-MS: ESI positive mode ([M+H]⁺ ≈ 818 Da). Tryptophan is light-sensitive; confirm the D-configured residues.
Stability Data
Representative stability behaviour under common storage, handling and formulation conditions.
| Condition | Duration | Result |
|---|---|---|
| Lyophilized, −20°C, dark | ≥ 24 months | No significant degradation (purity > 97%) |
| Lyophilized, 2–8°C, dark | ≥ 12 months | Minimal degradation (purity > 95%) |
| Lyophilized, 25°C (accelerated) | 3 months | < 5% degradation |
| Reconstituted, 2–8°C, dark | 7–14 days | Minor degradation |
| Reconstituted, 25°C | 24–48 h | Use promptly |
| Light exposure (ICH Q1B) | 1.2 M lux·h | Generally light-stable |
| Freeze–thaw (−20°C ⇄ 25°C) | 3 cycles | Acceptable — aliquot to avoid repeats |
- Keep lyophilized powder cold, dry and light-protected; keep any solution refrigerated and protected from light.
- Minimise freeze-thaw cycles; aliquot material used across many sessions.
- Key factor: Tryptophan is light-sensitive; confirm the D-configured residues.
Selected References
- Bowers CY. Growth-hormone-releasing peptide (GHRP) research (foundational literature).
- GHRP-2 / pralmorelin GH-stimulation-test clinical literature.
Quality & Supply
- HPLC ≥ 98% purity with a Certificate of Analysis per batch
- Identity confirmed by LC-MS
- Research samples through to bulk, with worldwide delivery
- Custom quantities and packaging on request
Need GHRP-2 — sample or bulk?
HPLC-verified, COA per batch. Tell us the quantity you need.
